Loading clinical trials...
Loading clinical trials...
A Prospective, Open, Comparative, Randomized Single-center Study to Evaluate the Effect of V.A.C. VeraFlo™ Therapy With .125% Dakins vs V.A.C. Ulta™ Therapy on Biofilm Removal/Disruption/Elimination in Chronically Infected Wounds
Conditions
Interventions
VAC VeraFlo with Dakins Instillation
VAC Ulta Therapy
Locations
1
United States
St. Luke's-Roosevelt Hospital Center
New York, New York, United States
Start Date
November 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
June 1, 2015
Last Updated
November 27, 2018
NCT01113658
NCT00852995
NCT00720239
NCT01050023
NCT00832091
Lead Sponsor
St. Luke's-Roosevelt Hospital Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions